Dr. Bouchard describes inciting medications and chronic management of Stevens-Johnson syndrome, which can be prevented with treatment that is both aggressive and early (less than 6 days). Eyelid scarring is typically the most critical prognostic factor, and systemic immunosupression should be used for all severe inflammatory diseases and any surface surgery. Additionally, contact lenses and serum tears can be of great help to these patients. Dr. Bouchard also advises cautions about central sterile melt in ocular surface surgery.